BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37787025)

  • 21. Omega-3 polyunsaturated fatty acids (n-3 PUFAs), somatic and fatigue symptoms in cardiovascular diseases comorbid major depressive disorder (MDD): A randomized controlled trial.
    Chang JP; Chang SS; Chen HT; Chien YC; Yang HT; Huang SY; Tseng PT; Chang CH; Galecki P; Su KP
    Brain Behav Immun; 2023 Aug; 112():125-131. PubMed ID: 37301235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial.
    Lin PY; Cheng C; Satyanarayanan SK; Chiu LT; Chien YC; Chuu CP; Lan TH; Su KP
    Brain Behav Immun; 2022 Jan; 99():289-298. PubMed ID: 34755655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of a high eicosapentaenoic acid multinutrient supplement on measures of stress, anxiety and depression in young adults: Study protocol for NutriMOOD, a randomised double-blind placebo-controlled trial.
    Kelaiditis CF; Gibson EL; Dyall SC
    Prostaglandins Leukot Essent Fatty Acids; 2021 Oct; 173():102335. PubMed ID: 34461561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of stearidonic acid on serum triacylglycerol concentrations in overweight and obese subjects: a randomized controlled trial.
    Pieters DJ; Mensink RP
    Eur J Clin Nutr; 2015 Jan; 69(1):121-6. PubMed ID: 25226826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A protocol for a randomised controlled trial investigating the effect of increasing Omega-3 index with krill oil supplementation on learning, cognition, behaviour and visual processing in typically developing adolescents.
    van der Wurff IS; von Schacky C; Berge K; Kirschner PA; de Groot RH
    BMJ Open; 2016 Jul; 6(7):e011790. PubMed ID: 27401364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy of omega-3 supplementation for major depression: a randomized controlled trial.
    Lespérance F; Frasure-Smith N; St-André E; Turecki G; Lespérance P; Wisniewski SR
    J Clin Psychiatry; 2011 Aug; 72(8):1054-62. PubMed ID: 20584525
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The mothers, Omega-3 and mental health study.
    Mozurkewich E; Chilimigras J; Klemens C; Keeton K; Allbaugh L; Hamilton S; Berman D; Vazquez D; Marcus S; Djuric Z; Vahratian A
    BMC Pregnancy Childbirth; 2011 Jun; 11():46. PubMed ID: 21696635
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ethyl-eicosapentaenoic acid omega-3 fatty acid supplementation on hot flashes and quality of life among middle-aged women: a double-blind, placebo-controlled, randomized clinical trial.
    Lucas M; Asselin G; Mérette C; Poulin MJ; Dodin S
    Menopause; 2009; 16(2):357-66. PubMed ID: 19034052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omega-3 fatty acid supplementation for cystic fibrosis.
    Watson H; Stackhouse C
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The differential effects of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) on seizure frequency in patients with drug-resistant epilepsy - A randomized, double-blind, placebo-controlled trial.
    Ibrahim FAS; Ghebremeskel K; Abdel-Rahman ME; Ahmed AAM; Mohmed IM; Osman G; Elseed M; Hamed A; Rabinowicz AL; Salih MAM; Elbashir MI; Daak AA
    Epilepsy Behav; 2018 Oct; 87():32-38. PubMed ID: 30170260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial.
    Dangour AD; Allen E; Elbourne D; Fasey N; Fletcher AE; Hardy P; Holder GE; Knight R; Letley L; Richards M; Uauy R
    Am J Clin Nutr; 2010 Jun; 91(6):1725-32. PubMed ID: 20410089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Omega-3 augmentation of sertraline in treatment of depression in patients with coronary heart disease: a randomized controlled trial.
    Carney RM; Freedland KE; Rubin EH; Rich MW; Steinmeyer BC; Harris WS
    JAMA; 2009 Oct; 302(15):1651-7. PubMed ID: 19843899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison between the AA/EPA ratio in depressed and non depressed elderly females: omega-3 fatty acid supplementation correlates with improved symptoms but does not change immunological parameters.
    Rizzo AM; Corsetto PA; Montorfano G; Opizzi A; Faliva M; Giacosa A; Ricevuti G; Pelucchi C; Berra B; Rondanelli M
    Nutr J; 2012 Oct; 11():82. PubMed ID: 23046564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dietary supplementation with eicosapentaenoic acid, but not with other long-chain n-3 or n-6 polyunsaturated fatty acids, decreases natural killer cell activity in healthy subjects aged >55 y.
    Thies F; Nebe-von-Caron G; Powell JR; Yaqoob P; Newsholme EA; Calder PC
    Am J Clin Nutr; 2001 Mar; 73(3):539-48. PubMed ID: 11237929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supplementation of n-3 Polyunsaturated Fatty Acids for Major Depressive Disorder: A Randomized, Double-Blind, 12-Week, Placebo-Controlled Trial in Korea.
    Park Y; Park YS; Kim SH; Oh DH; Park YC
    Ann Nutr Metab; 2015; 66(2-3):141-148. PubMed ID: 25824637
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced Symptoms of Inattention after Dietary Omega-3 Fatty Acid Supplementation in Boys with and without Attention Deficit/Hyperactivity Disorder.
    Bos DJ; Oranje B; Veerhoek ES; Van Diepen RM; Weusten JM; Demmelmair H; Koletzko B; de Sain-van der Velden MG; Eilander A; Hoeksma M; Durston S
    Neuropsychopharmacology; 2015 Sep; 40(10):2298-306. PubMed ID: 25790022
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II prospective randomized trial of a low-fat diet with fish oil supplementation in men undergoing radical prostatectomy.
    Aronson WJ; Kobayashi N; Barnard RJ; Henning S; Huang M; Jardack PM; Liu B; Gray A; Wan J; Konijeti R; Freedland SJ; Castor B; Heber D; Elashoff D; Said J; Cohen P; Galet C
    Cancer Prev Res (Phila); 2011 Dec; 4(12):2062-71. PubMed ID: 22027686
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No effect of n-3 long-chain polyunsaturated fatty acid (EPA and DHA) supplementation on depressed mood and cognitive function: a randomised controlled trial.
    Rogers PJ; Appleton KM; Kessler D; Peters TJ; Gunnell D; Hayward RC; Heatherley SV; Christian LM; McNaughton SA; Ness AR
    Br J Nutr; 2008 Feb; 99(2):421-31. PubMed ID: 17956647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential therapeutic impact of omega-3 long chain-polyunsaturated fatty acids on inflammation markers in Duchenne muscular dystrophy: A double-blind, controlled randomized trial.
    Rodríguez-Cruz M; Cruz-Guzmán ODR; Almeida-Becerril T; Solís-Serna AD; Atilano-Miguel S; Sánchez-González JR; Barbosa-Cortés L; Ruíz-Cruz ED; Huicochea JC; Cárdenas-Conejo A; Escobar-Cedillo RE; Yam-Ontiveros CA; Ricárdez-Marcial EF
    Clin Nutr; 2018 Dec; 37(6 Pt A):1840-1851. PubMed ID: 28987470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of change in omega-3 index with fish oil supplementation in peripheral artery disease.
    Drudi LM; Schaller MS; Hiramoto J; Gasper W; Harris WS; Hills NK; Grenon SM
    J Surg Res; 2017 Apr; 210():124-131. PubMed ID: 28457318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.